- EUR/USD grinds lower around three-month low, reverses early Asian gains of late.
- Stimulus, vaccine news keep risk appetite firmer despite covid woes.
- Bears seek PMIs to justify ECB’s dovish tilt, else Fed hawks can take over the next week.
EUR/USD remains pressured around 1.1770, unchanged on a day, heading into Friday’s European session. The sellers keep reins following the European Central Bank’s (ECB) bearish bias and amid the covid woes but a cautious optimism in the market seem to put a floor under the prices ahead of the key activity numbers from Germany, Eurozone and the US.
US policymakers stay hopeful of getting US President Joe Biden’s infrastructure spending bill passed through the house, despite being rejected for opening debate. The same join a relief to lawmakers offered by the US Congressional Budget Office (CBO) when it said, per Bloomberg, “US lawmakers likely have until October or November to raise or suspend the debt limit.” This will help the diplomats to have a bit more time than the July 31 deadline when the debt limit will need a change from the $22 trillion levels set in 2019.
While the risk-on catalysts challenge the US dollar bulls, ECB’s readiness to accept the change in rate guidance, due to the inflation jitters, keeps sellers hopeful. It should, however, be noted that the escalating covid woes in Australia and the UK, coupled with the gradually firming Delta COVID-19 cases in the bloc, challenge the optimism.
Against this backdrop, S&P 500 Futures print 0.23% intraday gains after Wall Street benchmarks closed positive for the third day in a row, grinding lower though.
Moving on, German PMIs are likely to be mixed, with Services fueling Composite figures, but the Eurozone numbers could be stronger and help the region’s currency. However, firmer data also raises doubts over the ECB performance, as Germany backs tapering, which in turn may restrict EUR/USD recovery. Following that, the US PMIs could print soft figures and facilitate the Fed’s move for the next week, likely dovish.
EUR/USD finally confirmed a “death-cross” bearish pattern, a 50-DMA run-up beyond 200-DMA suggesting a short-term downside. However, a 12-day-old falling trend line and support line of a monthly falling wedge, respectively around 1.1755 and 1.1725, will restrict the short-term EUR/USD downturn ahead of the yearly low near the 1.1700 round figures.
Additional important levels
|Today last price||1.1768|
|Today Daily Change||-0.0003|
|Today Daily Change %||-0.03%|
|Today daily open||1.1771|
|Previous Daily High||1.183|
|Previous Daily Low||1.1758|
|Previous Weekly High||1.188|
|Previous Weekly Low||1.1772|
|Previous Monthly High||1.2254|
|Previous Monthly Low||1.1845|
|Daily Fibonacci 38.2%||1.1785|
|Daily Fibonacci 61.8%||1.1803|
|Daily Pivot Point S1||1.1742|
|Daily Pivot Point S2||1.1713|
|Daily Pivot Point S3||1.1669|
|Daily Pivot Point R1||1.1815|
|Daily Pivot Point R2||1.1859|
|Daily Pivot Point R3||1.1888|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.